Genomictree, Inc. (228760) Financial Statements

― Followers

Genomictree, Inc. Financial Overview

Genomictree, Inc.'s market cap is currently ₩253.32B. The company's EPS TTM is ₩-334.06; its P/E ratio is -27.37; Genomictree, Inc. is scheduled to report earnings on August 7, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	₩ 3.76B	₩ 2.36B	₩ 3.42B	₩ 29.87B	₩ 5.14B
Gross Profit	₩ 73.36M	₩ -726.56M	₩ -270.02M	₩ 24.99B	₩ 2.52B
Operating Income	₩ -11.30B	₩ -15.31B	₩ -17.30B	₩ 8.90B	₩ -9.86B
EBITDA	₩ -10.28B	₩ -8.90B	₩ -6.27B	₩ 3.02B	₩ -5.80B
Net Income	₩ -8.99B	₩ -10.24B	₩ -8.76B	₩ -6.24B	₩ -11.42B
Balance Sheet
Cash & Short-Term Investments	₩ 77.37B	₩ 96.08B	₩ 93.15B	₩ 114.61B	₩ 130.53B
Total Assets	₩ 120.76B	₩ 130.68B	₩ 132.84B	₩ 162.91B	₩ 177.15B
Total Debt	₩ 2.37B	₩ 2.08B	₩ 1.83B	₩ 29.18B	₩ 38.44B
Net Debt	₩ -13.95B	₩ -24.27B	₩ -43.43B	₩ -38.39B	₩ -28.02B
Total Liabilities	₩ 5.45B	₩ 6.36B	₩ 7.81B	₩ 55.35B	₩ 62.05B
Stockholders' Equity	₩ 115.07B	₩ 123.88B	₩ 124.74B	₩ 107.05B	₩ 115.10B
Cash Flow
Free Cash Flow	₩ -9.97B	₩ -16.19B	₩ -11.17B	₩ 2.46B	₩ -19.46B
Operating Cash Flow	₩ -7.24B	₩ -13.63B	₩ -10.88B	₩ 4.29B	₩ -7.63B
Investing Cash Flow	₩ -2.93B	₩ -11.49B	₩ 8.12B	₩ 14.07B	₩ -49.07B
Financing Cash Flow	₩ 182.05M	₩ 6.02B	₩ -20.50B	₩ -19.52B	₩ 62.87B

Currency in KRW

Genomictree, Inc. Earnings and Revenue History

Income Statement >

Genomictree, Inc. Debt to Assets

Balance Sheet >

Genomictree, Inc. Cash Flow

Cash Flow >

Genomictree, Inc. Forecast EPS vs Actual EPS

Earnings >